Pediatric and Infectious Disease Unit, Bambino Gesu' Children's Hospital, IRCCS, Piazza Sant'Onofrio 4, Rome, Italy.
Pediatric Department, University of Tor Vergata, Rome, Italy.
Ital J Pediatr. 2018 Mar 14;44(1):36. doi: 10.1186/s13052-018-0474-0.
Vitamin K, a fat soluble vitamin, is a necessary cofactor for the activation of coagulation factors II, VII, IX, X, and protein C and S. In neonatal period, vitamin K deficiency may lead to Vitamin K Deficiency Bleeding (VKDB).
We present the case of a 2 months and 20 days Caucasian male, presented for bleeding from the injections sites of vaccines. At birth oral vitamin K prophylaxis was administered. Neonatal period was normal. He was exclusively breastfed and received a daily oral supplementation with 25 μg of vitamin K. A late onset vitamin K deficiency bleeding was suspected. Intravenous Vitamin K was administered with complete recovery.
Nevertheless the oral prophylaxis, our case developed a VKDB: it is necessary to revise the current guidelines in order to standardize timing and dosage in different clinical conditions.
维生素 K 是一种脂溶性维生素,是凝血因子 II、VII、IX、X 和蛋白 C、S 激活所必需的辅助因子。在新生儿期,维生素 K 缺乏可能导致维生素 K 缺乏性出血症(VKDB)。
我们报告了一例 2 个月零 20 天的白人男性,因疫苗注射部位出血就诊。出生时给予口服维生素 K 预防。新生儿期正常。他完全母乳喂养,并每天口服补充 25μg 的维生素 K。疑似迟发性维生素 K 缺乏性出血。给予静脉注射维生素 K 后完全康复。
尽管进行了口服预防,我们的病例仍发生了 VKDB:有必要修订当前指南,以规范不同临床情况下的时间和剂量。